Bleeding Tendency in Acute Promyelocytic Leukemia: Reversal by Cell Differentiation? View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1993

AUTHORS

P. W. Wijermans , G. J. Ossenkoppele , P. C. Huijgens , M. M. A. C. Langenhuijsen

ABSTRACT

Acute promyelocytic leukemia (APL) is a subvariety of acute myeloid leukemia (AML) and is associated with a high incidence of severe hemorrhage [7]. Tissue factor-like structures found on the leukemic blast cell, inducing disseminated intravascular coagulation (DIC), are often said to be responsible for this coagulopathy [2]. However, the observed bleeding disorder could not always be explained by DIC [5], and signs of fibrinolysis due to proteolytic lysosomal enzymes from the azurophilic granules were found [4]. Moreover, recently, specific fibrinolytic activity has also been described as a cause of the coagulopathy [6], and plasminogen activator has been found in the blast cells of patients with APL [3]. In a previous study [10] we investigated promyelocytic cell line cells (HL60) and blast cells from patients with APL and were able to show that in promyelocytes a combination of procoagulant activity (PCA) and proteolytic activity (lysosomal enzymes) exists that could be responsible for the observed bleeding tendency. Because HL60 cells are susceptible to differentiation in vitro to either more mature granulocytic or monocytic cells we are able to study whether combinations of PCA, proteolytic activity, and/or plasminogen activator activity exist in these cells, and whether these combinations are unique for the promyelocyte. We compared our findings with those obtained in blast cells of patients with different subtypes of AML. More... »

PAGES

65-69

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-77083-8_13

DOI

http://dx.doi.org/10.1007/978-3-642-77083-8_13

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025438239


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Haematology (BR 238), Free University Hospital, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Haematology (BR 238), Free University Hospital, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wijermans", 
        "givenName": "P. W.", 
        "id": "sg:person.010061377417.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ossenkoppele", 
        "givenName": "G. J.", 
        "id": "sg:person.0632272030.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632272030.13"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Huijgens", 
        "givenName": "P. C.", 
        "id": "sg:person.016705300364.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016705300364.60"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Langenhuijsen", 
        "givenName": "M. M. A. C.", 
        "id": "sg:person.0623621263.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623621263.00"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1993", 
    "datePublishedReg": "1993-01-01", 
    "description": "Acute promyelocytic leukemia (APL) is a subvariety of acute myeloid leukemia (AML) and is associated with a high incidence of severe hemorrhage [7]. Tissue factor-like structures found on the leukemic blast cell, inducing disseminated intravascular coagulation (DIC), are often said to be responsible for this coagulopathy [2]. However, the observed bleeding disorder could not always be explained by DIC [5], and signs of fibrinolysis due to proteolytic lysosomal enzymes from the azurophilic granules were found [4]. Moreover, recently, specific fibrinolytic activity has also been described as a cause of the coagulopathy [6], and plasminogen activator has been found in the blast cells of patients with APL [3]. In a previous study [10] we investigated promyelocytic cell line cells (HL60) and blast cells from patients with APL and were able to show that in promyelocytes a combination of procoagulant activity (PCA) and proteolytic activity (lysosomal enzymes) exists that could be responsible for the observed bleeding tendency. Because HL60 cells are susceptible to differentiation in vitro to either more mature granulocytic or monocytic cells we are able to study whether combinations of PCA, proteolytic activity, and/or plasminogen activator activity exist in these cells, and whether these combinations are unique for the promyelocyte. We compared our findings with those obtained in blast cells of patients with different subtypes of AML.", 
    "editor": [
      {
        "familyName": "Fleischer", 
        "givenName": "J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-77083-8_13", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-77085-2", 
        "978-3-642-77083-8"
      ], 
      "name": "Leukemias", 
      "type": "Book"
    }, 
    "keywords": [
      "acute promyelocytic leukemia", 
      "disseminated intravascular coagulation", 
      "acute myeloid leukemia", 
      "blast cells", 
      "procoagulant activity", 
      "promyelocytic leukemia", 
      "signs of fibrinolysis", 
      "proteolytic lysosomal enzymes", 
      "leukemic blast cells", 
      "cell line cells", 
      "intravascular coagulation", 
      "plasminogen activator activity", 
      "severe hemorrhage", 
      "myeloid leukemia", 
      "high incidence", 
      "bleeding disorder", 
      "proteolytic activity", 
      "different subtypes", 
      "azurophilic granules", 
      "monocytic cells", 
      "fibrinolytic activity", 
      "patients", 
      "plasminogen activator", 
      "leukemia", 
      "activator activity", 
      "lysosomal enzymes", 
      "HL60 cells", 
      "promyelocytes", 
      "line cells", 
      "cells", 
      "cell differentiation", 
      "specific fibrinolytic activity", 
      "previous studies", 
      "hemorrhage", 
      "fibrinolysis", 
      "activity", 
      "incidence", 
      "subtypes", 
      "disorders", 
      "differentiation", 
      "cause", 
      "coagulation", 
      "signs", 
      "combination", 
      "activator", 
      "findings", 
      "granules", 
      "study", 
      "reversal", 
      "tendency", 
      "enzyme", 
      "structure", 
      "subvarieties"
    ], 
    "name": "Bleeding Tendency in Acute Promyelocytic Leukemia: Reversal by Cell Differentiation?", 
    "pagination": "65-69", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025438239"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-77083-8_13"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-77083-8_13", 
      "https://app.dimensions.ai/details/publication/pub.1025438239"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_312.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-642-77083-8_13"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-77083-8_13'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-77083-8_13'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-77083-8_13'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-77083-8_13'


 

This table displays all metadata directly associated to this object as RDF triples.

130 TRIPLES      22 PREDICATES      78 URIs      71 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-77083-8_13 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N019bef50a80b4f8980b0b6539b416364
4 schema:datePublished 1993
5 schema:datePublishedReg 1993-01-01
6 schema:description Acute promyelocytic leukemia (APL) is a subvariety of acute myeloid leukemia (AML) and is associated with a high incidence of severe hemorrhage [7]. Tissue factor-like structures found on the leukemic blast cell, inducing disseminated intravascular coagulation (DIC), are often said to be responsible for this coagulopathy [2]. However, the observed bleeding disorder could not always be explained by DIC [5], and signs of fibrinolysis due to proteolytic lysosomal enzymes from the azurophilic granules were found [4]. Moreover, recently, specific fibrinolytic activity has also been described as a cause of the coagulopathy [6], and plasminogen activator has been found in the blast cells of patients with APL [3]. In a previous study [10] we investigated promyelocytic cell line cells (HL60) and blast cells from patients with APL and were able to show that in promyelocytes a combination of procoagulant activity (PCA) and proteolytic activity (lysosomal enzymes) exists that could be responsible for the observed bleeding tendency. Because HL60 cells are susceptible to differentiation in vitro to either more mature granulocytic or monocytic cells we are able to study whether combinations of PCA, proteolytic activity, and/or plasminogen activator activity exist in these cells, and whether these combinations are unique for the promyelocyte. We compared our findings with those obtained in blast cells of patients with different subtypes of AML.
7 schema:editor N37644c8a75af4aed841dd594618101ef
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N4395585eefcb4ddf8dd9b5a81c8868ae
11 schema:keywords HL60 cells
12 activator
13 activator activity
14 activity
15 acute myeloid leukemia
16 acute promyelocytic leukemia
17 azurophilic granules
18 blast cells
19 bleeding disorder
20 cause
21 cell differentiation
22 cell line cells
23 cells
24 coagulation
25 combination
26 different subtypes
27 differentiation
28 disorders
29 disseminated intravascular coagulation
30 enzyme
31 fibrinolysis
32 fibrinolytic activity
33 findings
34 granules
35 hemorrhage
36 high incidence
37 incidence
38 intravascular coagulation
39 leukemia
40 leukemic blast cells
41 line cells
42 lysosomal enzymes
43 monocytic cells
44 myeloid leukemia
45 patients
46 plasminogen activator
47 plasminogen activator activity
48 previous studies
49 procoagulant activity
50 promyelocytes
51 promyelocytic leukemia
52 proteolytic activity
53 proteolytic lysosomal enzymes
54 reversal
55 severe hemorrhage
56 signs
57 signs of fibrinolysis
58 specific fibrinolytic activity
59 structure
60 study
61 subtypes
62 subvarieties
63 tendency
64 schema:name Bleeding Tendency in Acute Promyelocytic Leukemia: Reversal by Cell Differentiation?
65 schema:pagination 65-69
66 schema:productId N5acec7255ffe499d859bd45925789353
67 N9f2b7e7375ae4272b0eeb32b89e98a36
68 schema:publisher N7177dcd9ce89414685fe47660eeacc2d
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025438239
70 https://doi.org/10.1007/978-3-642-77083-8_13
71 schema:sdDatePublished 2022-12-01T06:51
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N8b6e7ddc27d747c68b815e3034f720f2
74 schema:url https://doi.org/10.1007/978-3-642-77083-8_13
75 sgo:license sg:explorer/license/
76 sgo:sdDataset chapters
77 rdf:type schema:Chapter
78 N019bef50a80b4f8980b0b6539b416364 rdf:first sg:person.010061377417.22
79 rdf:rest Nb3dde60db96f4afea910c82bf57a56b9
80 N1ecd4ed84bdf4e879199f70fc1d93f8e schema:familyName Fleischer
81 schema:givenName J.
82 rdf:type schema:Person
83 N37644c8a75af4aed841dd594618101ef rdf:first N1ecd4ed84bdf4e879199f70fc1d93f8e
84 rdf:rest rdf:nil
85 N4395585eefcb4ddf8dd9b5a81c8868ae schema:isbn 978-3-642-77083-8
86 978-3-642-77085-2
87 schema:name Leukemias
88 rdf:type schema:Book
89 N5acec7255ffe499d859bd45925789353 schema:name dimensions_id
90 schema:value pub.1025438239
91 rdf:type schema:PropertyValue
92 N7177dcd9ce89414685fe47660eeacc2d schema:name Springer Nature
93 rdf:type schema:Organisation
94 N7b72406cb0a844008f3e720456f2f966 rdf:first sg:person.016705300364.60
95 rdf:rest Nd4a250ebf4de429299822183b18a3f45
96 N8b6e7ddc27d747c68b815e3034f720f2 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N9f2b7e7375ae4272b0eeb32b89e98a36 schema:name doi
99 schema:value 10.1007/978-3-642-77083-8_13
100 rdf:type schema:PropertyValue
101 Nb3dde60db96f4afea910c82bf57a56b9 rdf:first sg:person.0632272030.13
102 rdf:rest N7b72406cb0a844008f3e720456f2f966
103 Nd4a250ebf4de429299822183b18a3f45 rdf:first sg:person.0623621263.00
104 rdf:rest rdf:nil
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
109 schema:name Cardiorespiratory Medicine and Haematology
110 rdf:type schema:DefinedTerm
111 sg:person.010061377417.22 schema:affiliation grid-institutes:grid.16872.3a
112 schema:familyName Wijermans
113 schema:givenName P. W.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22
115 rdf:type schema:Person
116 sg:person.016705300364.60 schema:familyName Huijgens
117 schema:givenName P. C.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016705300364.60
119 rdf:type schema:Person
120 sg:person.0623621263.00 schema:familyName Langenhuijsen
121 schema:givenName M. M. A. C.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623621263.00
123 rdf:type schema:Person
124 sg:person.0632272030.13 schema:familyName Ossenkoppele
125 schema:givenName G. J.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632272030.13
127 rdf:type schema:Person
128 grid-institutes:grid.16872.3a schema:alternateName Department of Haematology (BR 238), Free University Hospital, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands
129 schema:name Department of Haematology (BR 238), Free University Hospital, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands
130 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...